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ABSTRACT 
 
 
 The purpose of this study was to evaluate the immunocontraceptive 
GonaCon™ in reducing fecundity in Eastern gray squirrel (EGS) (Sciurus 
carolinensis) in urban areas. Using a modified box trap design, 317 EGS were 
captured during four trapping sessions on a 5.66 ha site on Clemson 
University’s main campus.  EGS were handled using a restraint cone and 
sexed, weighed, ear-tagged and implanted with a microchip at the nape of the 
neck on all “original” captures and later identified in subsequent captures as 
“recaptures.” Blood samples and morphometric data were obtained on EGS 
before the immunocontraceptive GonaCon™ was administered by injection 
during three trapping sessions to 33 EGS (17m, 16f) in trapping session 1 
(TS1), 23 (14m, 9f) in trapping session 2 (TS2), and 11 (8m, 3f) in trapping 
session 3 (TS3) at a dosage rate of 0.4 ml containing 400 µg of GnRH-blue 
protein conjugate intramuscularly in the thigh. Control EGS were given a sham 
injection containing 0.4 ml saline- AdjuVac™ during the three trapping 
sessions:  22 EGS (16m, 6f) in TS1, 20 (12m, 8f) in TS2, and 8 (4m, 4f) in TS3. 
In the last trapping session (TS4) 35 EGS were necropsied to evaluate 
histological changes in testes and ovaries as potential metrics of GonaCon™ 
efficacy and to determine its potential side effects.  
  EGS density on the study area was estimated to be 9 ± (2.89) EGS/ha, 
based on the Lincoln-Peterson model.  There were no significant differences in 
body weights of treated and control EGS by TS3 (p = 0.40), or testosterone (p 
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= 0.32) and progesterone (p = 0.68) levels. However, there were significant 
differences in antibody titers between treated and control EGS by TS3 in both 
males and females active antibodies seen in the treatment group (χ2 = 5.656, 
df = 1, p = 0.017). There were highly significant differences in scrotal size of 
treated and control males with a reduction in scrotal size being observed in 
treated males (t= 10.14, df = 8, p = 0.001). There were marked histological 
changes in treated EGS males and no observable histological changes in 
treated EGS females. Although there were no serious side effects to the 
vaccine; 6 EGS developed injection site abscesses. GonaCon™ may be a 
potential tool to manage EGS overabundance in urban areas, but additional 
research is needed. 
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CHAPTER ONE 
 
 
IMMUNOCONTRACEPTION AS A TOOL TO MANAGE OVERABUNDANCE 
OF WILDLIFE POPULATIONS 
 
 
 One of the many spin-offs of a burgeoning human population is the 
shrinkage of wildlife habitats and the attendant overabundance of native species, 
or the invasion of introduced exotic species. This in turn shapes human tolerance 
of the presence and activities of free-ranging animals. The overabundances of 
native species with its negative ecological implications, and the invasion of exotic 
species with the consequent threat to native biota, are two faces of the same 
coin (Garrott et al. 1993).  The Eastern gray squirrel (Sciurus carolinensis) is a 
prime example of both of these scenarios. This species not only thrives well in its 
native range in the United States, but it is also considered invasive in England, 
because it has displaced and almost taken over the range of the endemic red 
squirrel (Sciurus vulgaris). The crux of the invasion process occurs in six stages: 
introduction, establishment, naturalization, dispersal, population distribution, and 
invasive spread (Henderson et al. 2006). In essence, overabundance can be 
insidious, and such animals are often categorized as nuisance wildlife.  
 Inferences drawn from invasion biology (Davis 2009) can be applied to 
overabundance: 
• Virtually all natural environments are prone to species invasion to some 
degree; 
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• The most reliable predictor of species invasion is resource availability, with 
both temporal and spatial variation in resources shown to be the primary 
mechanisms by which pools of resources are made available to incoming 
species; 
• Enemy and facilitator-related processes can be important in accounting for 
invasion in some instances, but neither has proven to be as reliable a 
predictor of species invasion as resource availability; 
• Diversity has not been shown to be a reliable predictor of species invasion 
under natural conditions at any spatial scale; and 
• The same processes affecting species invasion are driving diversity. 
 On another level, wildlife can be construed to be locally overabundant 
when in fact they may be threatened or endangered. For example, there has 
been an increase in the population densities of the African elephant (Loxodonta 
africana) in many of its range countries due to the control of poaching and a ban 
on ivory trade. As another example, the common leopard (Panthera pardus) has 
taken refuge in tea gardens of Assam, India, and breeds rather well in this 
alternate habitat.  African elephants and leopards are both endangered, yet 
overabundant in parts of Africa and India.  
According to Caughley (1981), the criteria for overabundance of animals can 
be based upon the degree in which they: 
• Threaten human life or livelihood, 
• Are too numerous for their “own good,” 
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• Depress the densities of economically or aesthetically important species, 
and 
• Cause ecosystem dysfunction. 
 The risk of zoonotic diseases such as avian influenza, rabies and 
tuberculosis gets compounded in the event of species overabundance.  The 
influenza virus is now known to jump between 3 taxonomic groups: avian, human 
and swine.  The overabundance of all the 3, in part, has resulted in the ongoing 
pandemic.  The intra-specific spread of diseases among wildlife populations is no 
less daunting, since many species in some areas exceed their carrying capacity 
(K). Two-thirds of the one-horned rhinoceros (Rhinoceros unicornis) in the world 
survive in the grasslands of Kaziranga in India; more than 2000 rhinos in only 
430 km2 of the national park. The risk of having “all eggs in one basket” is 
accentuated by overabundance. There is also a glut of many captive wildlife 
species in zoos across the world, leading to constraints in housing and captive 
breeding of endangered species.  
 Native and exotic species alike, can impact human health, national and 
local economies, and ecosystems and ecosystem services (Davis 2009). 
Ecosystem services are defined as the conditions and processes through which 
natural ecosystems, and the species that make them up, sustain and fulfill 
human life (Daily 1997). Overabundance of free-ranging wildlife populations 
interferes with ecosystem services, and therefore is an important driver of human 
wildlife conflicts. The newly emerged discipline of wildlife damage management 
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is primarily concerned with the challenges of controlling overabundant species 
and their negative impacts. However, a diagnosis of wildlife overabundance can 
only be made when placed in a specific context (McShea et al. 1997).  
 There are many examples where overabundant wildlife populations have 
created conflicts with humans and other wildlife. For example, white-tailed deer 
(Odocoileus virginanus), Canada geese (Branta canadensis), African elephants 
(Loxodonta africana), and rhesus macaques (Macaca mulatta) have become 
problem species on a community, and in some cases on a landscape scale. In 
North America, white-tailed deer populations in some areas became 
overabundant in the mid-seventies. Increasing suburbanization and concurrent 
decreases in agricultural land use created large areas of predator-scarce habitat 
(Diamond 1992, McCullough et al. 1997). In South Carolina, because of 
expanding populations, white-tailed deer have been reported to cause an 
estimated $52.4 million dollars in damage to agricultural production in one year 
(Smathers et al. 1994).  Conover (et al. 1995) reported an estimated 29,000 
human injuries and 211 human fatalities each year as a result of 726,000 deer-
vehicle accidents annually in the U.S.  In 1991, there was a conservative 
estimate of over 538,000 deer deaths in 36 states as a result of deer-vehicle 
collisions (Lehnert and Bissonette 1997).  
  Overabundance of Canada geese is well documented in many areas of 
the U.S., with geese- inflicted damage to grain and forage crops.  In addition, the 
presence of feeding geese on lawns, in parks, on golf courses and in backyards 
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has sparked ire among many residents of several U.S. cities (Conover and 
Chasko 1985).  In Ghana and Zimbabwe, the African elephant long afforded 
protection from poaching and overexploitation, has created new conflicts. 
Elephant densities have swelled to such an extent that they freely roam 
communal lands, depredate crops and compete for scarce water resources 
(Lamarque et al. 2005). India has an overabundance of rhesus macaques and 
laws banning their export (Mandavalli 2006). This has led to high conflict levels in 
urban areas in recent times. In Italy, gray squirrel (Sciurus carolinensis) 
populations introduced to a broad-leaf forest patch in 1970, are now 
overabundant and likely to spread throughout Europe and Asia (Bertolino and 
Genovesi 2003).  
 Management programs that address conflicts caused by wildlife 
overabundance have four parts that include 1) problem identification, 2) ecology 
of the problem species, 3) application of control methods, and 4) evaluation of 
control efforts (Dolbeer et al. 1994). Problem definition refers to determining the 
species and numbers of wildlife causing a particular problem, the amount of loss 
or nature of the conflict, and other biological and social factors related to the 
problem.  Understanding the ecology and life history of a species is important in 
wildlife damage management, especially in context of understanding cause of 
conflicts and potential solutions.  Application of control methods utilizes an 
understanding of the ecology of a particular species to develop an appropriate 
management program to reduce conflict(s). Evaluation of control efforts helps to 
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assess the effectiveness of control methods in reducing or eliminating conflicts in 
a safe, humane, cost-effective, and socially acceptable manner.  
 Traditional techniques that have been used to reduce negative impacts 
associated with wildlife overabundance include 1) excluding problem wildlife, 2) 
habitat modification, 3) frightening problem wildlife, 4) repelling problem wildlife, 
5) live trapping and removal of problem wildlife, 6) lethal methods, or 7) a 
combination of the above techniques (Hygnstrom et al. 1994).  
 Exclusion involves keeping problem wildlife out of an area using physical 
barriers. Examples include woven wire fences, electric fences, or any other 
barrier that prevents entry or access into an area that needs protection 
(Hygnstrom et al. 1994). For example, physical barriers have been used by land 
managers and conservation agencies in Australia to exclude feral cats (Felis 
cattus), red fox (Vulpes vulpes) and European rabbits (Oryctolagus cuniculus) 
(Moseby and Read 2006). All three species were introduced to Australia by 
Europeans and have successfully colonized much of mainland Australia. Fences 
are typically installed to reduce white-tailed deer damage in the U.S. and 
materials may include wire or plastic mesh, electrified high-tensile steel wire, and 
electrified polytape (VerCauteren et al. 2006) 
 Habitat modification as a means of reducing wildlife damage involves 
removing habitat components (e.g. food, shelter, and water) to make areas less 
desirable for problem wildlife species (Hygnstrom et al. 1994).  For example, 
Canada geese require open areas to feed and can be discouraged by 
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landscaping an area with trees, bushes, hedges, boulders, or anything that 
geese would have difficulty seeing around.  In addition, draining unwanted ponds 
that are adjacent to open areas (e.g. lawns) has been effective in making areas 
less inviting to geese (Conover 2002). In some cases, habitat modification may 
include enhancing habitat components in areas to attract wildlife away from sites 
that need protection. An example is planting food crops for white-tailed deer to 
“lure” them away from ornamental plantings and gardens in residential areas 
where they may cause damage.  
 Frightening can also be used to temporarily “scare” wildlife away from 
areas to reduce potential conflicts. A variety of frightening devices are used to 
move wildlife from local areas and include pyrotechnics, gas exploders, effigies, 
lights, lasers, reflectors, guard animals, bioacoustics and ultrasonic devices 
(Hygnstrom et al. 1994).  These techniques are often more effective when used 
in an integrated system that incorporates multiple stimuli (Gilsdorf et al. 2002).  
 A variety of repellents have been used to keep wildlife away from 
protected areas. Repellents work by creating an aversion response based on 
taste, touch or smell (Hygnstrom et al. 1994). There are two general categories 
of repellents, primary and secondary.  Primary repellents work with disruptive 
stimuli and affect normal behaviors of an animal. Secondary repellents work with 
aversive stimuli and affect occurrence of specific negative behaviors (Shivik et al. 
2003).  An example of a primary repellent is the use of predator odors, such as 
red fox or raccoon (Procyon lotor) urine smeared on butternuts, which repels 
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gray squirrels (Rosell 2001).   An example of secondary repellents is the use of 
chili grease smeared on coir rope around the periphery of rice fields to deter 
elephants by conditioned taste aversion (Sitati and Walpole 2006).  
 Live-trapping involves removing problem wildlife by trapping and 
relocating to areas where conflicts are less likely to occur. There are pros and 
cons in trapping and relocating problem wildlife. For example, relocation of 
problem black bears (Ursus americanus) using culvert-traps to capture bears 
was used in northeastern Oregon as an alternative to lethal removal of bears that 
attacked sheep (Armistead et al. 1994). Although relocation costs did not differ 
from that of killing depredating bears, the former method had better social 
acceptance.  Some state wildlife agencies (e.g. South Carolina), however, do not 
allow live-trapping and relocation of wildlife, especially problem wildlife.  
Concerns center around survivability of relocated wildlife, impacts of relocated 
wildlife on other species, and the potential for disease transmission (Cunningham 
1996).  
 The use of lethal methods to control populations of overabundant wildlife 
involves killing animals by shooting, lethal traps, or poisoning.  With game 
species, populations are regulated through recreational hunting.  Public 
acceptance and stakeholder support of lethal methods to control wildlife 
overabundance is not universally accepted in some areas across the world.  
However, removal of some species using lethal means has a legitimate role in 
wildlife conservation (Treves and Naughton-Treves 2005).  A case in point is the 
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hunting of white-tailed deer in North America, which provides recreation for 
sportsmen and revenue for conservation as well.    
 Several experimental approaches to address wildlife overabundance and 
associated conflicts are currently being tested and evaluated, one of which is the 
use of anti-fertility vaccines. The development of anti-fertility vaccines is an 
offshoot of similar technologies used in the prevention of infectious diseases 
(Tizard 2009).  In one example, an antigen in the form of a protein, elicits an 
immune response when administered to a healthy animal, leading to the 
production of antibodies. This reaction is used to intercept critical steps in the 
production and secretion of sex hormones such as estrogen and testosterone. 
The net result is diminished reproduction or its cessation.  This technology has 
been in vogue for several years and has been tested on a variety of species with 
varying success (Miller et al. 1998). Reversible sterilization of wildlife by holding 
them in permanent care facilities has proven to be a good management option 
for some species such as the African elephant and cheetah.  However, the use of 
anti-fertility vaccines on free-ranging animals is often complicated by legal, 
biological, economic and ethical issues (Guynn 1993).  
 The goal of contraceptive vaccines can be categorized as either 
immunocontraception or immunoneutering.  Immunocontraceptive vaccines aim 
to prevent fertilization of the oocyte by sperm or implantation of the fertilized egg 
while retaining sexual behavior patterns and competition in mating. 
Immunocontraception works on both sexes, but depending on the species, is 
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only used on one of the sexes. Immunocontraceptives (specifically GonaConTM ) 
prevent production and/or maturation of gametes. This approach has gained 
acceptance by some for control of feral animal pests or native wildlife.  
Immunoneutering vaccines aim to prevent all sexual behaviors in both male and 
female animals, as well as control fertility. These outcomes are suitable for 
companion animals, livestock, and in some instances feral animals perceived as 
pests (Meeusen et al. 2007). 
 Antigens of the gametes (sperm and oocytes) have widely been targeted 
for prevention of fertilization in a variety of animals. A suite of over 20 sperm 
antigens have been identified and characterized, and may ultimately serve as 
potential vaccines in some animals. Most of these are surface proteins and 
include sperm antigens SP10, SP17, FA-1, LDH-C4, and PH-20 (Delves et al. 
2002). However, side effects like autoimmune-mediated orchitis and lack of good 
results in contraception, have led to a focus on vaccinating the female with 
oocyte antigens.  
 Fertility levels in vaccinated females are generally reduced from levels of 
75% to 80%, to levels of 25 to 30%, in a variety of species including mice (Lea et 
al. 2002), baboons (Stevens 1997), and guinea pigs (Tung et al. 1997). Among 
the oocyte antigens, a family of surface antigens from the zona pellucida (ZP) 
has been identified as providing effective immunocontraception (Meeusen et al. 
2007). In 1988, Kirkpatrick et al. (1990) tried a failed human contraceptive called 
porcine zona pellucida (PZP) on wild horses on Assateague Island, off the 
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Maryland and Virginia coast in the U.S.. Zona pellucida proteins distilled from pig 
ovaries were injected into mares, and these foreign proteins prompted their 
immune systems to manufacture antibodies against the antigens. The antibodies 
latched onto the surface of newly ovulated mare oocytes, blocking sperm from 
entering and fertilizing the egg (Fox 2007). The vaccine was refined so that one 
inoculation rendered wild horses infertile for two years (Turner et al. 2007). 
SpayVac (Immuno Vaccine Technologies, Canada), a vaccine based on a crude 
PZP antigen preparation, has also been available for experimental wildlife 
population control.  
 The most studied and best characterized hormone used as a vaccine 
target has been luteinizing-hormone releasing hormone (LHRH), also known as 
gonadotropin-releasing hormone (GnRH). GnRH is the key hormone controlling 
reproductive function and development and is released from the hypothalamus. It 
is a simple 10-amino acid peptide that is found in all species of mammals, with 
variants identified in other organisms from lampreys to birds and fish. 
Immunoneutralization of this pivotal hormone of the pituitary-gonadal axis has 
been demonstrated to prevent reproductive function, provide contraception in 
mammals, control estrus behavior in females, and sexual aggression behavior in 
males (Meeusen et al. 2007).  GonaCon™ is an example of an anti-GnRH 
vaccine developed by researchers at the USDA National Wildlife Research 
Center (NWRC) (Miller et al. 2004). In a recent (October 2009) and significant 
development, GonaCon™ was registered for use in white-tailed deer by the  U.S. 
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Environmental Protection Agency (EPA), whose responsibility is to register 
products for use in wildlife. GonaCon™ is based on a peptide antigen mollusk 
hemocyanin carrier protein conjugate in an oil-based adjuvant (AdjuVacTM). This 
formulation has the effect of making the skin of vaccinated animals test positive 
for Mycobacterium avium. The vaccine has proved to be effective in species such 
as deer (Gionfriddo et al. 2006), bison (Miller et al. 2004), wild horses (Killian et 
al. 2006), wild boar (Massei et al. 2008), feral cats (Levy et al. 2004), and 
California ground squirrels (Nash et al. 2004).  
 The goal of this research project study was to field test the vaccine 
GonaCon™ in Eastern gray squirrels (EGS). Specific objectives of the project 
were the following:  
1. To evaluate the efficacy of GonaCon™ in reducing EGS fecundity in urban 
areas;  
2. To determine appropriate metrics for evaluating the success of 
GonaCon™; and 
3. To provide recommendations for the use of GonaCon™ as a potential tool 
for reducing EGS overabundance in urban areas. 
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CHAPTER TWO 
 
 
FIELD TRIALS OF GONACON™ VACCINE IN  
EASTERN GRAY SQUIRRELS  
 
 
Biology and Ecology of Eastern Gray Squirrels 
 The Eastern gray squirrel (Sciurus carolinensis; Sciurus, in the shadow of 
the tail; carolinensis, first identified in the Carolinas) is a common and prolific 
tree-dwelling rodent endemic to urban areas of the eastern United States 
(Thompson and Thompson 1980).  It is one of several native species of tree 
squirrels found in North America (e.g. fox squirrel, S.niger; western gray squirrel, 
S. griseus; Abert’s squirrel, S. aberti; Arizona gray squirrel, S. arizonensis; 
Mexican fox squirrel, S. nayaritensis; pine squirrel, Tamisciurus hudsonicus; and 
Douglas’ squirrel, T. douglasii). The historic range of the Eastern gray squirrel 
(referred to in both singular and plural as EGS) was comprised of eastern North 
America, until its spread due to numerous introductions.  Presently, outside of its 
historic range, the species is extant in California, Montana, Oregon, Oklahoma 
and Washington in the US.  In North America it is also found in Quebec, New 
Brunswick, British Columbia, Manitoba, Nova Scotia, Ontario, and Saskatchewan 
in Canada (Robinson and Cowan 1954).  EGS have also been introduced in Italy, 
England, Scotland, and Ireland (Lloyd 1983).  
 The EGS is a medium-sized tree squirrel that does not display sexual 
dimorphism in size or color (Koprowski 1994). Total body length is 380 – 525 mm 
and adult body mass ranges from 300 – 710 g (Schwartz and Schwartz 1981). 
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The dorsal pelage is dark to pale gray; the fur may be cinnamon colored on the 
hips, feet, and head; and the ventral side is white or gray, to buff or cinnamon 
(Flyger and Gates 1982). Ears are buff to gray or white, and the long, bushy tail 
is white to pale gray and 150 – 250 mm in length (Koprowski 1994). Both 
melanism and albinism are common in EGS (Steele and Koprowski 2001).   The 
only natural sympatric congener of the EGS is the fox squirrel, which is 20% 
larger in body mass and brown to black in color (Koprowski 1994).  
EGS prefer large tracts of dense, mature hardwoods, especially oaks 
(Quercus spp.) and hickories (Carya spp.), with an understory of smaller trees 
and shrubs. The fox squirrel, on the other hand, prefers open park-like stands of 
pine (Pinus spp.), mixed pine, and oak or oak-gum (Nyssa spp.) -cypress 
(Taxodium spp.) stands. Of the two, the EGS is by far the most abundant and it is 
numerous enough to manage for recreational hunting purposes (Yarrow and 
Yarrow 1999).  
 EGS feed heavily on nuts, flowers, and buds of nearly 24 oak species, 10 
species of hickory and pecan (Carya illinoensis), walnuts (Juglans spp.), and 
American beech (Fagus grandifolia) when available (Nixon et al. 1968). Other 
important foods include fruits, seeds, buds, or flowers of maples (Acer spp.), 
mulberry (Morus spp.), hackberry (Vaccinum spp.), elms (Ulmus spp.), buckeye 
and horse chestnuts (Aesculus spp.), wild cherries (Prunus spp.), dogwoods 
(Cornus spp.), hawthorn (Crataegus spp.), black gum (Nyssa sylvatica), 
hazelnut (Corylus spp.), hop hornbeam (Ostrya virginiana), and gingko (Gingko 
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biloba) (Thompson and Thompson 1980).  A variety of herbaceous species are 
also eaten; fungi are readily consumed in summer. Cultivated crops such as 
corn and wheat are also eaten.  EGS are known to feed on insects, bones, bird 
eggs and nestlings, and frogs (Koprowski 1994). Cannibalism has also been 
reported (Holm 1976). Predators of EGS include rat snakes (Elaphe spp.); red-
tailed (Buteo jamaicensis), red-shouldered (Buteo lineatus), marsh (Circus 
cyaneus), and Cooper’s hawks (Accipiter cooperii); great horned (Bubo 
virginianus) and barred owls (Strix varia); red (Vulpes vulpes) and gray (Urocyon 
cinereoargenteus) foxes; bobcats (Felis rufus); raccoons (Procyon lotor); house 
cats (Felis catus), and domestic dogs (Canis lupus familiaris). However, these 
predators do not limit EGS population growth in most areas.  Since EGS habitat 
conditions are constantly in a state of flux, other factors regulate their 
reproductive rates. These factors make EGS population densities cyclical. 
Whenever an EGS population exceeds the carrying capacity of a forest stand, a 
mass movement and relocation of squirrels to other areas may take place. This 
exodus may involve thousands of EGS, many of which die during the journey 
(Yarrow and Yarrow 1999).  
 EGS typically have two breeding periods: the first between December and 
January, with litters produced between March and April (spring) (Gurnell 1983, 
1987). The second breeding period is between May and June, with litters 
produced between July and August (summer) (Gurnell 1983, 1987). Female EGS 
can become sexually mature at 5.5 months of age (Smith and Barkalow 1967), 
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but most do not reproduce until after 1.25 years (Brauer and Dusing 1961). 
Gestation period is 44 days (Webley and Johnson 1983) and average litter size is 
2 – 3 (Lurz et al. 2002). EGS may have 1, 2, or no litters during a single 10 – 
month period (Nixon and McClain 1975). Although males become sexually 
mature at 10 to 11 months of age (Kirkpatrick and Hoffman 1960), they undergo 
a semiannual cycle of testicular recrudescence and regression. This in turn 
impacts their sexual behavior and entire breeding seasons may sometimes be 
skipped (Webley et al. 1985). Spring-born males remain sexually active for 6–8 
months, while summer-born males are sexually active for about 3 months. Both 
groups undergo sexual degeneration in the late summer months (Kirpatrick and 
Hoffman 1960).  In the wild, EGS rarely live more than 6 years (Uhlig 1955), 
although their ecological longevity may be up to 9 years.  
 
Problems Associated with Eastern Gray Squirrels  
 A tendency for wildlife species to show changes in their behavioral 
characteristics and population densities relative to urban areas is termed 
“synurbanization” (Parker and Nilon 2008).  The EGS is a case in point. For 
instance, EGS in parks surrounded by greater levels of urbanization (more 
buildings and less trees) will exhibit higher population densities, increased rates 
of intraspecific aggression, increased activity levels, and reduced wariness 
(Parker and Nilon 2008).  Consequently, high EGS densities often increase 
conflicts with humans as well as other wildlife.  
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The invasiveness and expansion of the EGS has caused problems to 
native fauna and humans in its extended range (Lurz et al. 2002, Lever 1994). 
Damage and death of hardwood trees by EGS, through bark stripping and 
gnawing, might be a result of territorial marking or agonistic gnawing behavior 
(Kenward and Parish 1986), and possibly also due to their high densities 
(Koprowski 2005). Densities of EGS are normally <3/ha in continuous woodlands 
(Barkalow et al. 1970), while EGS densities in small (<10 ha) woodlots can be 
16/ha (Doebel and McGinnes 1974), and in urban parks can be > 21/ha (Manski 
et al. 1981).  
EGS also impact the production of cash and orchard crops like walnuts, 
cherries, and pears, since they prefer to eat the nuts and fruits of these trees, as 
well as cache them.  EGS are prone to travel power lines and short-out electrical 
transformers in urban areas causing power outages. They are known to enter 
buildings and houses, gnawing on electrical wires which increase the risks of 
fires, and build nests in attics destroying attic insulation.  Other problems 
associated with high EGS densities include destruction of lawns associated with 
caching behavior; consumption of bird feeder food and damage to bird feeders; 
enlargement of bird house openings; predation on nestling songbirds; and 
damage to ornamental plants, planted seedlings, and fruits of planted shrubs and 
trees (Hygnstorm et al. 1994).  
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Current Techniques to Reduce Conflicts with Eastern Gray Squirrels 
 
Exclusion 
 Exclusion involves keeping problem EGS out of an area using physical 
barriers. Examples may include woven wire fences, electric fences, or any other 
barrier that prevents entry or access into an area that needs protection 
(Hygnstrom et al. 1994). EGS can be prevented from climbing isolated trees and 
power poles by encircling them with a metal collar 1.8 m off the ground (Jackson 
1994).   Where EGS are entering buildings, a squirrel excluder can be improvised 
by mounting a 46-cm section of 10-cm plastic pipe over an opening (Jackson 
1994). A one-way door can also be used over an opening to let squirrels out and 
prevent them from returning.  Openings to buildings can also be closed using 
heavy 1.3-cm wire mesh.  Custom-designed wire mesh fences topped with 
electrified wires have been effective in keeping EGS out of gardens or small 
orchards. 
 
Habitat Modification 
 Habitat modification as a means of reducing EGS damage involves 
removing habitat components (e.g. food, shelter, or water) to make areas less 
desirable for EGS (Hygnstrom et al. 1994).  Limbs and trees can be trimmed 1.8 
to 2.4 m away from buildings to prevent EGS from jumping on to roofs   (Jackson 
1994).  EGS can be kept away from bird feeders by tying an ear of corn away 
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from where they are causing problems. In some cases, agricultural producers 
have cleared trees near orchards to limit incursion and damage of orchard trees.  
 
Repellents 
 A variety of repellents have been used to keep EGS away from protected 
areas. Repellents work by creating an aversion response based on taste, touch 
or smell (Hygnstrom et al. 1994). Ropel® is a taste repellent for EGS that can be 
applied to seeds, bulbs, and flowers; trees and shrubs; poles and fences; siding 
and outdoor furniture (Jackson 1994).  Capsaicin is also a taste repellent, 
registered for use on maple sap collecting equipment.  Polybutenes are sticky 
materials that can be applied to buildings, railings, downspouts, and other areas 
to keep EGS from climbing.  
 
Trapping 
 Trapping can either be categorized as capturing live EGS or utilizing lethal 
traps that kill EGS. Live-trapping involves removing problem EGS by trapping 
and relocating to areas where conflicts are less unlikely to occur. A variety of 
traps can be used to catch EGS, including No. 0 or No. 1 leg hold traps, box 
traps, and cage traps (Jackson 1994). Glue boards, that are used to capture rats, 
have also been used to catch small EGS.  Since EGS are classified as game 
species in most states, trapping permits may be required from state wildlife 
agencies to trap and release problem EGS.  The South Carolina Department of 
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Natural Resources does not permit the trapping, translocation and releasing of 
EGS because of the stress placed on transported and released EGS, as well as 
potential impacts on resident EGS populations and concerns regarding the 
transmission of diseases.  Snap traps used for rats can be used as lethal traps 
for small EGS.  Effective baits to attract EGS to traps are slices of orange and 
apple, walnuts or pecans removed from the shell, and peanut butter (Jackson 
1994). Other foods familiar to the EGS may also work well, such as corn or 
sunflower seeds. 
 
Shooting 
 Where firearms are permitted, shooting is an effective control method to 
reduce EGS populations and associated problems.  A shotgun with No. 6 shot or 
a .22-caliber rifle is suitable. However, state wildlife agency regulations and local 
ordinances need to be met, as well as the social acceptability of shooting EGS.  
 
Other Methods 
 Often several control methods used simultaneously are more successful 
at reducing EGS conflicts than a single technique (Jackson 1994). For example, 
to remove EGS from an attic, they should be observed to determine their entry 
and exit portal.  After this a combination of repellents and lights may be used to 
drive them out, followed by closing entry openings.  Baited traps can also be 
used to capture any EGS that may have been accidentally closed in with 
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exclusion. This last step is important since “locked-in” EGS may cause damage 
when they try to chew their way out. Regardless of the technique(s) used, EGS 
damage in yards, gardens, forests, and orchards is often very difficult to control.  
 
Immunocontraceptives and GonaCon™ 
 Before the advent of GonaCon™, traditional immunocontraceptive 
research was restricted to the use of a vaccine made from zona pellucida 
extracted from the ovaries of pigs (Sus scrofa) and named porcine zona pellucida 
(PZP) (Miller et al. 1999).  GonaCon™ is an immunocontraceptive vaccine that 
induces the immune system to generate antibodies to native (“self”) gonadotropin 
releasing hormone (GnRH).  This is accomplished by conjugating GnRH to a 
foreign protein.  Because the animal’s immune system has not been previously 
exposed to the foreign protein, it generates antibodies to both the foreign protein 
and to GnRH.  The hypothalamus releases GnRH which then travels to the 
anterior pituitary, stimulating the release of leuteinizing hormone (LH), and to a 
lesser extent, follicle stimulating hormone (FSH).  These two hormones then 
trigger the release of testosterone, estradiol, and progesterone from the testes or 
ovaries.  Testosterone is necessary for breeding behavior and the production of 
sperm.  Estradiol plays a crucial role in egg development and quality; whereas, 
progesterone is needed for ovulation and maintenance of pregnancy. Antibodies 
bind native GnRH as it leaves the hypothalamus, thus preventing it from binding 
to receptors in the anterior pituitary.  As a result, no LH and little FSH is released 
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from the pituitary.  Without the stimulus of LH and FSH, the testes and ovaries do 
not produce testosterone, progesterone, and produce little estradiol. Therefore 
no sperm or eggs are produced.  Developed as a single-shot vaccine, 
GonaCon™ has been proven has been proven efficacious for ≥ 2 years in many 
pest species including white-tailed deer, domestic and feral pigs, bison, wild 
horses, cats and dogs (Miller et al. 2004).  The GnRH immunocontraceptive 
vaccine has been successfully used on rats (Rattus norvegicus) and California 
ground squirrels (Spermophilus beecheyi) (Miller et al. 1997, Nash et al. 2004). 
Using only a single shot, its effects typically last ≥ 2 years which means it could 
render a rodent, like EGS, permanently infertile due to the short life span of 
rodents.  There is no danger to non-targets since the vaccine is injected directly 
into the target animal.  The vaccine consists of proteins; therefore, a secondary 
consumer is unlikely to be contracepted as proteins are broken down in the 
stomach.  Although research continues on the development of an oral 
GonaCon™ immunocontraceptive, animals must currently be captured and 
injected by hand with a GonaCon™ vaccine.   
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Objectives and Methods 
 
The purpose of this study was to field test the immunocontraceptive 
GonaCon™ as a potential vaccine to prevent reproduction in EGS in urban 
areas.  Objectives of the study were the following: 
1. To evaluate the efficacy of GonaCon™ in reducing EGS fecundity on the 
campus of Clemson University,  
2. To evaluate the use and appropriateness of various metrics in determining 
the effectiveness of GonaCon™ in reducing EGS fecundity, and 
3. To evaluate the use of GonaCon™ as a potential tool to reduce EGS 
overabundance in urban areas and provide recommendations for further 
research. 
 
Study Area  
 Field trials examining the effects of GonaCon™ on EGS were conducted 
on Clemson University’s (CU) main campus from March 2008 to June 2009. The 
CU campus, located in northwestern South Carolina, is composed of 
approximately 325 ha of teaching, research and administrative buildings 
interspersed with about 6600 trees (primarily oak, Quercus spp.; and hickory, 
Carya spp.), in addition to landscaping shrubs and bushes. Past estimates of 
EGS densities on CU’s campus were higher (4.7 EGS/ha) than what has been 
reported in nonurban wooded habitats (0.6-3.8 EGS/ha) (Hein 1997).  CU’s 
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landscaping crew has documented over 100 mature trees killed, and an 
additional 100 trees severely damaged on CU’s main campus by EGS for an 
estimated $ 1.3 million in damage (Carson, pers. comm.).  
The study area consisted of 5.67 ha on CU’s main campus (Figure 1), and 
was selected based on the following criteria:  
• A visible overabundance of EGS, 
• Ease of access to study animals, and 
• Proximity to project research facilities at CU. 
 
Eastern Gray Squirrel Trapping 
 EGS were captured on a 5.67 ha study site on Clemson University’s main 
campus during four trapping sessions (TS1 = March – April 2008, TS2 = July 
2008, TS3 = November 2008, and TS4 = May – June 2008) using a modified 
wooden box trap design (Mosby 1955).  Forty wooden box traps (Table 1) were 
baited with a mixture of corn and oiled sunflower seeds during each of the four 
trapping sessions. The trap design (Mosby 1955) allowed a welded-mesh funnel 
and collar to be securely fastened to the front end of the trap. A slotted nylon 
capture cone made was tied on to the collar to facilitate EGS handling (Figure 2).  
 A total of 317 EGS (117 originals and 200 recaptures) were captured 
during the study.  EGS were handled using the restraint cone and sexed, 
weighed, ear-tagged and implanted with a numbered microchip directly under the 
skin on the nape of all “originals”, and then later identified as “recaptures” during 
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subsequent trapping sessions. EGS were vaccinated with GonaCon™ before the 
onset of their breeding season so they could be potentially contracepted before 
breeding began. On trapping, each EGS received either GonaCon™ or a sham 
control on the basis of toss of a coin for a randomized treatment design.  The first 
trapping session (TS1) was conducted during March – April 2008 and 33 EGS 
were administered GonaCon™ and 22 a sham control. The ensuing breeding 
season of May – June 2008 was missed and the second trapping session (TS2) 
was conducted in July 2008. The third trapping session (TS3) was conducted in 
November 2008. The last session (TS4) corresponded with the May – June EGS 
breeding season. Thirty five EGS captured during TS4 were euthanized and 
necropsied for histological assessments.  
 Traps were set at dawn and remained open until dusk. Traps were 
checked at one hour intervals and all trapped EGS were processed in a timely 
manner (mean handling time = 10 minutes) and released at the trap site.  
Captured EGS normally moved into the restraining cone once the trap door was 
opened.  If not, handlers used noise or aerosol cans of compressed air to move 
EGS into the cone. The cone worked well as a restraint device and EGS were 
easily handled, examined, treated and released.  
 
Morphometric Data from Study Animals 
 EGS were sexed based on their external genitalia and presence of 
mammary glands.  Lactation in females was assessed, as well as scrotal 
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pigmentation and testicular development in breeding males, as indicators of 
potential fertility.  Presence or absence of lactation was determined by 
appearance of teats and milk secretions.  Females were determined to be 
lactating if they had swollen teats with little or no hair covering them.  Pigmented 
teats indicated that females had pups in the past.  Testicular development was 
assessed on the basis of size in mm.  Length and width of both control and 
treated EGS male scrotums were measured with digital calipers and scrotal size 
was used to assess age classes, in addition to being a potential metric for 
evaluating the effect of the vaccine. Furthermore, males were considered to be 
breeding if they had a gray or black pigmented scrotum with little hair covering 
the scrotum as well as enlarged testes.  Males were considered to be non-
breeding if they had a pink pigmented scrotum with hair regrowth evident and 
small flaccid testes (Pudney 1976, Webley et al. 1985, Ferryman et al. 2006).   
 A combination of pelage characteristics and body weights were used to 
assign an age class to individuals (Dimmick and Pelton 1996).  Although scrotal 
pigmentation can be used in aging male EGS, the appearance of sub-adult and 
adult males with regressed testes can often be confusing (Hoffman and 
Kirkpatrick 1959). Skeletal and tooth characteristics, as well as dry weight of eye 
lens has been used to estimate EGS age, but these methods require euthanizing 
the animal.  EGS age classes for the purpose of this study were defined as the 
following: juvenile: 0 – 6 months of age; sub-adult: 6 – 12 months of age; and 
adult: > 12 months of age.  
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 All “original” and “recaptured” EGS were weighed using a digital weighing 
scale (Slater 1kg scale).  The null hypothesis that body weights would not differ 
between treated and control EGS was tested.  
 
Identification of Study Animals 
 EGS were ear-tagged for easy recognition. Self-piercing and uniquely 
numbered ear tags (Model 1005-1, National Band and Tag, Newport, KY) were 
applied with tag-pliers at the thickest part of the cartilage in the pinna of both 
ears.  Ear-tag color codes used for identifications were the following;                
red = control female, white = treated female, yellow = control male, and blue = 
treated male.  
 Passive Integrated Transponder (PIT) microchip tags were inserted under 
the skin at the nape to serve as a second identifier in the event that ear tags 
were inadvertently pulled or fell out of EGS ears. Prior to insertion PIT tags, were 
scanned to verify that they worked and to record the number on data sheets 
(Table 3). The dorsal skin between the scapulas was pinched to form a “tent” and 
pit tags were delivered subcutaneously using a syringe and insertion needle.  As 
the needle was withdrawn, the injection site was pinched off to ensure that the 
PIT tag would not fall out. EGS were then scanned to verify that PIT tags 
remained functional.  
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Estimation of Eastern Gray Squirrel Densities  
 Pooled capture-mark-recapture data were used to estimate EGS densities 
for each trapping session on the study site using the Lincoln-Peterson method 
(Gerhardt 2005). The sampling design for the basic capture–recapture model for 
estimating the size of a closed population involves randomly capturing EGS (n0) 
from the population, tagging and releasing them, and later capturing a second 
EGS sample of size (n1) and looking at the number of tagged EGS (m1) in the 
second sample. The Lincoln–Peterson model was used to express the equation 
NLP = (n1xn2)/m2. The assumption of a closed population in this density estimation 
was likely not violated, because EGS in this study had a high site fidelity based 
on high recapture rate in each of the trapping sessions.  
 
Formulation of GonaCon™  
 The GnRH vaccine construct was developed by the USDA National 
Wildlife Research Center (NWRC) in Fort Collins, Colorado. The 10-amino acid 
GnRH peptide hormone was made immunogenic by coupling the peptide to a 
mollusk hemocyanin. The GnRH used in this study was synthesized at 
Macromolecular Resources, Colorado State University (Fort Collins, CO,) with 
the structure [pEHWSYGLRPGGC-SH]. The underlined amino acids represent the 
native GnRH molecule. A glycine was added at the C terminus as a spacer, and 
a cysteine was added to ensure consistent alignment of the peptide to the 
maleamide-activated mollusk protein. The aqueous-based GnRH conjugate was 
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combined in a 1:1 ratio by volume with a novel adjuvant (AdjuVac™), which is an 
oil-based adjuvant containing small quantities of killed Mycobacterium avium.  
GonaCon™ is supplied in refrigerated, 3ml, pre-loaded syringes (NWRC SOP BT 
016.02).  
 
GonaCon™ Treatment of Eastern Gray Squirrels 
 GonaCon™ was given by injection to 33 (17m, 16f), 23 (14m, 9f) and 11 
(8m, 3f) EGS at a dosage rate of 0.4 ml containing 400 µg of GnRH-blue protein 
conjugate intramuscularly in the thigh during three trapping sessions (TS1, TS2, 
TS3). A sham injection containing 0.4 ml saline- AdjuVac™ was administered to 
22 (16m, 6f), 20 (12m, 8f) and 8 (4m, 4f) control EGS during the same three 
sessions (NWRC SOP BT 004.01). EGS were randomized by the toss of a coin 
to receive either a GonaCon™ or a sham injection.  
 
Methodology for Collecting and Processing Blood 
 A method of collecting blood from laboratory mice was modified for EGS 
(Hoff 2000). The saphenous vein, found on the caudal surface of the thigh, 
served as the site of veinpuncture and blood collection from EGS.  After hair was 
removed from the area with the aid of clippers, the skin over the vein was 
prepped with isopropyl alcohol. The vein was then punctured using a 20 gauge 
needle and drops of blood were collected in serum separation tubes. Bleeding 
was then stopped by applying pressure. EGS blood samples were centrifuged to 
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separate serum and serum was stored in a freezer (-20. C) until assayed for 
steroid hormones and antibodies (NWRC SOP FP 030.00) 
 
Scrotal Size Measurements 
 The length and width of scrotums were measured with digital calipers in 
both treated and control EGS males for the 3 trapping sessions (Table 4).  The 
null hypothesis that scrotal size would not differ between treated and control 
males was tested.  
 
Determination of Progesterone and Testosterone Concentrations  
 Radioimmunoassay (RIA) on EGS sera samples from treated and control 
females, and treated and control males, was performed to measure the 
progesterone and testosterone concentrations, respectively (NWRC SOP BT 
025.00).  The assays were performed using Coat-A-CountTM kits from Diagnostic 
Products Corporation (Los Angeles, CA).  Repeat samples from EGS captured 
over at least two trapping sessions were used for assays to compare hormonal 
levels over time. For progesterone assays, treated females (n = 12) and control 
females (n = 7) were assessed for changes in progesterone concentrations 
(Table 6). Similarly, treated males (n = 7) and control males (n=7) were assessed 
for changes in testosterone concentrations (Table 5).  The null hypothesis that 
testosterone concentrations would not differ between treated and control males 
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was tested. Similarly, the null hypothesis that progesterone concentrations would 
not differ between treated and control females was tested.  
 
Detection of GnRH Antibodies  
 In order to detect GnRH antibodies from study animals over time, repeat 
samples from EGS captured over at least two trapping sessions were tested to 
detect antibodies to GonaCon™.  Enzyme-linked immunosorbent assay (ELISA) 
on sera samples from treated females (n = 5) and control females (n = 4), and 
treated males (n = 6) and control males (n = 4) were performed (Table 7) (NWRC 
SOP BT 017.00). The ELISA assessed the immune response of EGS to the 
GnRH vaccine by detecting GnRH antibodies in EGS serum. Anti-rabbit IgG 
labeled with horseradish peroxidase was used to detect the quantity of bound 
antibody. The null hypothesis that antibody titers would not differ between treated 
and control EGS was tested.  
 
Statistical Analysis  
 Descriptive statistics (mean ± S.E.) were calculated for continuous 
variables. Proportions or ratios were calculated for categorical variables in each 
group. Continuous variable means were compared over time between treatments 
and controls (testosterone and progesterone concentrations, scrotal size) using 
one-way repeated measures analysis of variance (ANOVA) followed by the pair 
wise t –test and trend analysis to generate graphs. Level of significance was set 
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at 0.05. Categorical variables (GnRH antibody titers) were compared over time 
and between treatments and controls using Fisher’s exact test of proportions. All 
statistical calculations were performed using Proc GLM and Proc frequency of 
SAS.  
 
Results 
Eighty nine EGS were trapped on the 5.65 ha study site on CU’s main 
campus from March-April 2008 (TS1: first trapping session).  During July 2008 
(TS2: second trapping session) 114 EGS were trapped, and in November 2008 
(TS3: third trapping session) 79 EGS were trapped. During May-June 2009 (TS4: 
fourth trapping session) 35 EGS were trapped for necropsy examination. A total 
of 317 EGS were captured during the study (Table 1 and 2).  
 
Eastern Gray Squirrel Densities 
 The Lincoln–Peterson model (NLP = (n1xn2)/m2 ) was used to estimate 
ESG numbers on the study site where: 
      NLP = EGS population estimate; 
                  n1  = Number of EGS originally trapped, tagged, and released; 
                  n2    = Number of EGS trapped subsequently with and without tags;  
                  m2  = Number of EGS trapped subsequently with original tags. 
For TS1, NLP     = (65x42)/45 = 80 EGS on the study site, and density  
        (D) = 80/5.67 ha ≈  14 EGS/ha 
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For TS2, NLP     = (43x73)/71 = 49 EGS on the study site, and density  
        (D) = 49/5.67 ha ≈    9 EGS/ha 
For TS2, NLP     = (19x64)/60 = 20 EGS on the study site, and density  
        (D) = 20/5.67 ha ≈    4 EGS/ha 
       Mean (D)  = 9 ± (2.89) 
 
Body Weight Measurements  
 Body weight measurements were obtained from 33, 23, and 11 treated 
EGS; and 32, 20, and 8 control EGS over 3 trapping sessions (TS1, TS2, TS3), 
respectively. During TS1 the mean body weights (± SE) for treated and control 
EGS were 463.94 ± 12.37 and 455.31 ± 12.49 grams, respectively across all age 
classes and both sexes. These means were not significantly different (t = - 0.49, 
df = 63, p = 0.63). During TS2 mean body weights for treated and control EGS 
were 453.91± 16.46 and 448.00 ± 16.60 grams, respectively. These means were 
not significantly different (t = - 0.25, df = 40, p = 0.80). During TS3 the mean body 
weights for treated and control EGS were 451.00 ± 25.74 and 419.00 ± 27.22 
grams, respectively. These means were not significantly different (t = - 0.86, df = 
16, p = 0.40). Pooled data for control and treated EGS was used in the analysis 
above (Figure 9) since there is no sexual dimorphism in size.  
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Scrotal Size Measurements 
 Twenty one scrotal size measurements (length x breadth) collected over 3 
trapping sessions (TS2, TS3, TS4) from 7 control and 7 treated EGS males were 
tested for differences. Scrotal size measurements were compared between 
treated and control males within each session and across all three sessions as 
well.  
 During TS2 mean scrotal size for treated males was 110.99 ± 96.68 mm 
and for control males 118.63 ± 127.39 mm. However, these means were not 
significantly different (t= 0.08, df = 8, p = 0.93). 
During TS3 mean scrotal size for treated males was 45.61 ± 76.76 mm 
and for control males 109.16 ± 133.02 mm. However, these means were not 
significantly different (t= 76.76, df = 8, p = 0.56).  
During TS4 mean scrotal size for treated males was 141.46 ± 76.76 mm 
and for control males 1101.75 ± 108.63 mm. These means were significantly 
different (t= 10.14, df = 8, p = 0.001) indicating a significant difference in scrotal 
size of treated and control EGS with a reduction in scrotal size being observed in 
treated males (Figure 10).   
 
Hormone Concentrations 
Testosterone Assays 
 Thirty three serum samples were collected over 3 trapping sessions (TS1, 
TS2, TS3) from 7 control and 7 treated EGS and analyzed using RIA.  During 
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TS1, the mean testosterone concentration for treated males was 0.33 ± 0.14 
ng/ml and for control males 0.34 ± 0.15 ng/ml. However, these means were not 
significantly different (t= 0.04, df = 15, p = 0.96).  
 During TS2, mean testosterone concentration for treated EGS males was 
0.34 ± 0.13 ng/ml and for control males 0.28 ± 0.12 ng/ml. However, these 
means were not significantly different (t= -0.32, df = 15, p = 0.74). During TS3, 
mean testosterone concentration for treated EGS males was 0.45 ± 0.09 ng/ml 
and for control males 0.62 ± 0.13 ng/ml. However, these means were not 
significantly different (t= 1.02, df = 15, p = 0.32) There were no differences 
between testosterone concentrations of treated and control EGS by the third 
trapping session (Figure 11).  
 
Progesterone Assays 
 Thirty serum samples were collected over 3 trapping sessions (TS1, TS2, 
TS3) from 12 treated and 7 control EGS females and analyzed using RIA. During 
TS1, mean progesterone concentration for treated females was 1.67 ± 0.93 
ng/ml and for control females 1.26 ± 1.19 ng/ml. However, these means were not 
significantly different (t= - 0.29, df = 8, p = 0.78).  
            During TS2, mean progesterone concentration for treated females was 
0.93 ± 1.69 ng/ml and for control females 1.86 ± 1.31 ng/ml. However, these 
means were not significantly different (t= 0.43, df = 8, p = 0.68).   During TS3, 
mean progesterone concentration for control females was 4.64 ± 1.13 ng/ml. 
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There were no significant differences between the progesterone 
concentrations of treated and control EGS females by the third trapping 
session (Figure 12).  
 
Antibody Titers  
Seventy serum samples were collected over 3 trapping sessions (TS1, 
TS2, TS3) from 9 control and 7 treated EGS females, and 9 control and 7 treated 
EGS males. Samples were analyzed for the presence of active antibodies to 
GnRH using ELISA.   
During TS1, the ratio of treated EGS with active antibodies was 1:8 and 
the ratio of control EGS with active antibodies was 0:11. These ratios were not 
significantly different (χ2 = 1.286, df = 1, p = 0.256). During TS2, the ratio of 
treated EGS with active antibodies was 2:7 and the ratio of control EGS with 
active antibodies was 12:6. These ratios were significantly different (χ2 = 4.747, 
df = 1, p = 0.029). During TS3, the ratio of treated EGS with active antibodies 
was 0:5 and the ratio of control EGS with active antibodies was 7:4. These ratios 
were significantly different (χ2 = 5.656, df = 1, p = 0.017).  
ELISA showed significant differences between the antibody titers of 
treated and control EGS by the third session (Figure 13). However, 5 control 
animals, 3 females and 2 males, showed high antibody titer.  
 
  
37 
 
Injection Site Reactions and Mortalities  
 There were 4 injection site abscesses in treated and 2 in control EGS. The 
ratio of injections given to the occurrences of abscesses at the site of injection for 
treated EGS was 40:4 and 33:2 for control EGS. These ratios were not 
significantly different. (χ2 = 0.3167, df = 1, p = 0.5736) Two EGS died as a result 
of trap failure, and 3 animals died as a result of predation injuries, possibly from a 
raptor, during the period of study.  
 
Discussion 
 The results of the controlled efficacy trial demonstrate that peak antibody 
titers of 1:12,800 were induced both in male and female EGS by a single 
injection of 400 µg of GonaCon™ when tested 2 months post-treatment. This is 
consistent with similar responses to GnRH in male cats (Levy et al. 2004), male 
dogs (Ladd et al. 1994), female white-tailed deer (Curtis et al. 2007), and female 
wild boar (Massei et al. 2008).  Five control EGS showed high titer levels likely 
due to an inexplicable sampling error. The possibilities include a recording error, 
laboratory error, or the inadvertent vaccination of control EGS with GonaCon™.  
However, antibody titers are a good metric and an important pointer to the 
immunogenic success of GonaCon™ immunocontraception.  
 Hormonal assays proved to be inconclusive, because there were no 
significant differences in either progesterone or testosterone concentrations 
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between treated or control EGS.  This likely is due to the fact that blood was not 
collected from EGS during the peak of breeding seasons.  
 The blood collection technique used in this study does not seem to be an 
appropriate one for hormonal assays that are colorimetric. Evidently, the EGS 
blood samples clotted rapidly, and this led to hemolysis when serum was 
separated. In the presence of hemolyzed serum, the concentration of a hormone 
or antibodies will be lowered and the results thereby affected. Therefore, a better 
blood sampling technique needs to be used.  
 The findings in 14 EGS males (7 treated and 7 control) in TS2, TS3 
and TS4) indicated a significant reduction in scrotal size in GonaCon™ treated 
males by TS4, as compared to control males. Although there seemed a 
substantial difference in scrotal size in TS3 as well, this was not significant likely 
due to a small sample size or the large variances observed. The marked 
difference seen in TS4 was likely due to sustained vaccine effects that had, in all 
likelihood, caused a marked reduction in the scrotal size by TS4. This 
corresponds with differences in mean testicular weights of treated and control 
EGS on necropsy examination (Table 9). The reduction in scrotal size of treated 
males is an indicaton that GonaCon™ possibly caused immunological castration 
in male EGS, which is in agreement with an similar response seen in male dogs 
and male cats treated with a similar immunocontraceptive vaccine (Ladd et al. 
1994, Levy 2004).  
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 GonaCon™ did meet an important criterion of an ideal contraceptive 
vaccine, as it did not cause any significant differences in body weights between 
treated and control EGS. However, the vaccine did cause injection site reactions 
in 6 EGS as seen in other studies (Miller et al. 2008; Tizard 2009). This problem 
can likely be overcome when an improved vaccine formulation is designed by the 
manufacturer.  
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CHAPTER 3 
 
 
HISTOLOGICAL CHANGES IN THE GONADS OF EASTERN GRAY 
SQUIRRELS VACCINATED WITH THE IMMUNOCONTRACEPTIVE 
GONACON™ 
 
 
Introduction 
 There have been occasional reports of adverse effects of vaccines in 
animals. Although often mild, these effects have included allergic reactions and 
the development of sarcomas in cats (Tizard 2009). The absence of harmful 
side effects is one important attribute of an ideal contraceptive. However, some 
studies have documented pathological impacts on the reproductive tract with the 
use of both immunocontraceptive vaccines and hormonal contraceptives.  The 
Porcine vaccine zona pellucida (PZP) resulted in ovarian lesions in white-tailed 
deer (Curtis et al. 2007).  Endomterial hyperplasia, hydrometra and uterine 
infections have occurred in melengestrol acetate (MGA) treated ungulates 
(Munson 2005).  
 GonaCon™ primarily blocks the entry of GnRH into the hypophsis of the 
pituitary gland, and thereby suppresses steroidogenesis, oogenesis, and 
spermatogenesis (Robbins 2004). The gonads are an important source of the 
sex hormones – testosterone in the male, and estrogen and progesterone in the 
female. It is probable that reversible or irreversible histological changes occur in 
the testes and ovaries as a result of GonaCon™ vaccination. A GnRH-KLH 
vaccine similar to GonaCon™ caused testicular atrophy in cats (Levy et al. 
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2004). However, testicular atrophy may be a desired effect as long as it does 
not negatively impact the health of the animal.  
Histological changes in the testes and ovaries of 35 EGS were evaluated 
as metrics of effectiveness for GonaCon™ in EGS.  Detailed necropsies of EGS 
were conducted to assess ovarian and testicular abnormalities, or other potential 
health concerns resulting from the vaccination (Table 1 and 2).  Objectives of this 
study were the following: 
1. To evaluate histological changes in testes and ovaries as a metric to 
determine the effectiveness of GonaCon™ in reducing EGS fecundity, and 
2. To determine any potential side effects in EGS treated with either the 
GonaCon™ vaccine or sham control injections. 
 
Materials and Methods 
Reproductive Anatomy of Male Eastern Gray Squirrels  
 In adult EGS males, the testes lie in scrotal sacs on either side of the 
penis. The prostate is a single, elongated, compact gland located in the proximity 
of the urinary bladder and attached to the muscular part of the urethra (Allanson 
1933). The seminal vesicles are small and adhere closely to the prostate.  A pair 
of large spirally wound Cowper’s glands are located at the sides of the rectum 
and lie embedded in the fascia of the thigh. A long thick duct passes from each to 
open into the bulb of the urethra. The penis is sharply bent backwards at its distal 
end. In sub-adult and juvenile male EGS, the testes lie subcutaneously on each 
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side of the penis. The accessory glands are small and the seminal vesicles and 
Cowper’s glands are difficult to distinguish (Allanson 1933). 
 
Reproductive Anatomy of Female Eastern Gray Squirrels  
 The female EGS has a duplex uterus with two cervices, no uterine body, 
and horns completely separated (Deanesley and Parkes 1933). The uterus is 
large and contains multiparous arteriopathies in the endometrium in the parous 
female. In the prepubertal female, the flattened cornua are small and threadlike. 
Externally, the surface of ovaries is similar for both prepubertal and parous 
females; however, the ovarian mass is greater in parous females (Nixon and 
McClain 1975).  Internally, the ovaries of the EGS resemble those of Norway 
rats (Rattus norvegicus) or house mice (Mus musculus), with comparatively little 
interstitial tissue (Deanesley and Parkes 1933).  
 
Study Area 
 Experimental field trials of GonaCon™ were conducted on Clemson 
University’s (CU) main campus located in northwestern South Carolina. The 
campus is approximately 325 ha of teaching, research and administrative 
buildings interspersed with about 6600 trees (primarily oaks Quercus spp., and 
hickories Carya spp.), in addition shrubs and bushes used for landscaping. 
Densities of EGS are normally <3 EGS/ha (Barkalow et al. 1970).  Using Lincoln-
Peterson model, EGS density was estimated to be 9 EGS/ha on the study area.  
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Vaccine Formulation  
 Both male and female EGS were vaccinated with either GonaCon™ 
(treatment) or a sham-injection (control) prepared and supplied by the USDA 
National Wildlife Research Center (NWRC, Fort Collins, CO). Treated EGS were 
injected with 0.4 ml of GonaCon™ which contained 1000 micrograms GnRH-blue 
protein conjugate per ml; therefore, each 0.4 ml dose contained 400 µg GnRH-
blue conjugate. Control EGS were injected with 0.4 ml saline-Adjuvac 
intramuscularly in the thigh.  
 
Vaccination Protocol 
 Using a modified wooden box trap design (Mosby 1955), 99 EGS were 
captured from March-April 2008 (first trapping session = TS1). During July 2008 
(second trapping session = TS2), 114 EGS were captured, and in November 
2008 (third trapping season = TS3) 80 EGS were captured on the study. EGS 
were handled using a restraint cone, sexed, weighed, ear-tagged, and implanted 
with a microchip under the skin in the nape of all “originals” and read as 
“recaptures” on subsequent trapping.  
 Vaccination with GonaCon™ or sham-controls was conducted by 
intramuscular injection in the thigh of both male and female EGS.  GonaCon™ 
was administered to 33, 23 and 11 EGS during the three respective trapping 
sessions (TS1, TS2, and TS3). EGS were released at the site of capture after 
treatment.  Sham injections were administered intramuscularly in the thigh to 22, 
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20 and 8 EGS during the same three trapping sessions as treated EGS. EGS 
were randomized by the toss of a coin to receive either a GonaCon™ or a sham 
injection.  
 
Eastern Gray Squirrel Necropsies 
 In April and May of 2009, 35 EGS were humanely euthanized by an 
overdose of halothane anesthesia (CU RS/SOP 300-04-02). Necropsy 
examinations were performed on all 35 EGS; 18 males (8 treated 10 control) and 
17 females (8 treated 9 control) (Table 9 and 10).  All necropsies were performed 
within 10 minutes after EGS were euthanized. Gross examinations and 
measurements included body weights, body condition, internal organs, weights of 
testes and ovaries, examination of injection sites, and documentation of any 
visible abnormalities.  Ovaries, uteri and mammary glands were collected from 
females and fixed in 10% neutral buffered formalin (NBF) (Gugic et al. 2007). 
Testes and prostate glands were collected from males and fixed in modified 
Davidson’s fluid (Latendresse et al. 2002).  The pituitary gland was collected 
from both sexes and fixed in 10% NBF. Histological examination was conducted 
after tissues were embedded in paraffin, and stained with hematoxylin-eosin 
(Allanson 1933). Prepared histological slides were interpreted by a veterinary 
pathologist using an optical microscope (Nikon A2100 microscope equipped with 
DS-Ri1 color camera). 
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Terms of Reference  
 Seminiferous tubules in the testes are the specific site for the process of 
cellular differentiation to generate mature spermatozoa. Each testis contains 
many seminiferous tubules, which are connected at both ends to a collecting 
system called the rete testis. A degeneration of seminiferous tubules will disrupt 
the process of sperm production leading to infertility (Ogawa et al. 1997).  
 Sertoli cells or nurse cells line the seminiferous tubules and nurture 
spermatogenesis.  The relationship between germ cells and Sertoli cells is 
important and obligatory (Griswold 1995).  Evidence of cavity formation in the 
Sertoli cells with resultant shedding of immature sperm cells is termed 
vacuolation (Hild et al. 2001).  
 The interstitial cells (Leydig cells) in the testes secrete testosterone, are 
rich in lipid droplets, and have a cord-like arrangement. These cells provide 
spaces that improve cell secretion of hormones and facilitate transport into the 
blood (Hafez et al. 1997). In the event of testicular atrophy, a decrease in number 
and size of Leydig cells will occur, and testosterone production will be impaired 
as a result.  
  
Statistical Analysis  
 Descriptive statistics (mean ± S.E.) were calculated and normally 
distributed data over time (organ weights and diameter) were compared using 
one-way repeated measures analysis of variance (ANOVA) using the general 
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linear models procedure (Proc GLM) of SAS software (Version 9.1). This was 
followed by a pair wise t –test and trend analysis to generate graphs. Level of 
significance was set at p = 0.05.  
 
Results  
 Gross and histological examination were conducted on 8 treated males, 
10 control males, 8 treated females, and 9 control female EGS. Mean wet testes 
weight of control EGS males was 4010 ± 704.64 mg and 336 ± 61.22 mg for 
treated males. There was a significant reduction in testes weights in treated 
males (t = 5.19, df = 8.12, p = 0.0008).   
 The proportion of treated EGS males with degeneration of seminiferous 
tubules was 1.0, and the proportion of control males with degeneration of 
seminiferous tubules was 0. These proportions were significantly different (χ2 = 
18.0, df = 1, p = 0.0001). 
 The proportion of treated EGS males with atrophy of Leydig cells was 1.0, 
and the proportion of control males with atrophy of Leydig cells was 0. These 
proportions were significantly different (χ2 = 18.0, df = 1, p = 0.0001).  
 The proportion of treated EGS males with vacuolation of Sertoli cells was 
1.0, and the proportion of control males with vacuolation of Sertoli cells was 0. 
These proportions were significantly different (χ2 = 18.0, df = 1, p = 0.0001).  
 Mean wet weight of ovaries of control EGS females was 103 ± 25.96 mg 
and 98 ± 8.61 mg for treated EGS females and were not significantly different (t = 
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0.17, df = 9.73, p = 0.86). There were no significant differences in the diameter of 
the uterine horns and the length of the tract from the vagina to the ovaries 
between control and treated EGS females. There were no pregnancies found in 
either control or treated EGS females.  
 Representative cross sections of testes in control EGS males exhibited 
densely packed tubuli seminiferi with intact spermatogenesis (see arrow) and 
robust looking interstitial Leydig cells (Figure 3.A) In treated EGS males atrophic 
tubuli seminiferi and Leydig cells (see arrow) with degenerating spermatocytes 
are seen (Figure 3.B). 
Figure 1. Cross-section of testes of control (A) and GonaConTM treated (B) EGS 
males (H&E stain, Bar = 90 µm). 
 
 
 Representative cross sections of epididymis in control EGS males 
exhibited a lumen filled with abundant mature spermatozoa (see arrow) (Figure 
4.A). In treated EGS males lumen devoid of spermatozoa are seen (arrow) 
(Figure 4.B).  
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Figure 2. Cross-section of epididymis of control (A) and GonaCon™ treated (B) 
EGS males (H&E stain, Bar = 90 µm). 
 
Representative cross sections of prostates in control EGS males exhibited 
normal glandular epithelium (see arrow) (Figure 5.A). In treated EGS males 
contracted dark glandular tissue and evidence of advanced atrophy is seen 
(arrow) (Figure 5.B). 
Figure 3. Cross-section of prostate of control (A) and GonaCon™ treated (B) 
EGS males (H&E stain, Bar = 90 µm). 
 
Representative cross sections of ovaries in control and treated EGS 
females did not exhibit any observable differences (Figure 6) 
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Figure 4. Cross-section of ovaries of control (A) and GonaCon™ treated (B) 
EGS females (H&E stain, Bar = 90 µm). 
 
 Representative cross sections of uterus in control and treated EGS 
females did not exhibit any observable differences (Figure 7).  
 
Figure 5. Cross-section of uterus of control (A) and GonaConTM treated (B) EGS 
females (H&E stain, Bar = 90 µm). 
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Representative cross sections of pituitary gland in control and treated 
EGS of both sexes did not exhibit any observable differences (Figure 8). 
Figure 6. Cross-section of pituitary gland of control (A) and GonaCon™ treated 
(B) EGS males. (H&E stain, Bar = 90 µm). 
 
Discussion 
  The findings in 18 necropsied EGS males (8 treated and 10 control) 
indicated a reduction in testes weight (90%) in GonaCon™ treated males, as 
compared to control males.  There were also marked histological differences in 
the testes of treated males, as compared to control males. This suggests that 
GonaCon™ treated male EGS were immunoneutered, and exhibited physiologic 
traits similar to castrated males. These findings are consistent with studies in 
other animals, such as GonaCon™ treated male white-tailed deer, where testes 
size was also reduced as a result of anti-GnRH immunocontraception (Curtis et 
al. 2008, Pooler 2001, Killian et al. 2006).   
 Specific histological changes represented in comparisons of 8 treated 
EGS males and 10 control males that were necropsied included degeneration of 
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seminiferous tubules, atrophy of Leydig cells and vacuolated Sertoli cells. 
Degeneration of seminiferous tubules with concomitant diminished 
spermatogenesis observed in treated EGS males in this study, were also 
observed in similar studies in Sprague-Dawley rats (Jinshu et al. 2005), white-
tailed deer (Curtis et al. 2008), dogs (Ladd et al. 1994), cats (Levy et al. 2004), 
and Scottish Suffolk-crossbred rams (Ferro et al. 2004). Atrophy of Leydig cells 
and vacuolated Sertoli cells observed in treated male EGS was also seen in male 
cats that received anti-GnRH vaccine (Levy et al. 2004).  
 Male EGS have one unique physiologic attribute that is germane to the 
question: whether marked histological changes that were observed in this study 
were permanent or transient?  It is well documented that male EGS undergo a 
semiannual cycle of testicular recrudescence and regression and occasionally 
skip entire breeding seasons (Webley et al.1985). Consequently, it is difficult to 
preclude the possibility that the histological findings that imply a cessation of 
reproduction in GonaCon™ treated male EGS in this study were not due to the 
phenomenon of sexual quiescence.  
 No histological changes in uteri or ovaries were discerned in the 8 
GonaCon™ treated EGS females on necropsy. Changes in hormonal levels over 
the estrous cycle of EGS results in morphological changes in the ovary, uterus, 
and vagina, all of which can be used to determine the stage of cycle (Davis et al. 
2001). In other words, no histological changes observed in both GonaCon™ 
treated and control EGS females in this study could well conform to females that 
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were in anestrous or sexual rest, a normal physiologic process in the 
reproductive cycles of not only rodents but all mammalian females (Conaway 
1971). On the other hand, it could well mean that the treated EGS females were 
in senescence. Several factors contribute to the variability in timing of 
reproductive senescence in rodents, including the species, environmental 
factors, and whether pregnancy actually occurred (Davis et al. 2001).   
 Even if GonaCon™ is effective only in male EGS, it might still help reduce 
or alleviate territorial marking and bark stripping, which seems to be a learned 
behavior in male EGS (Kenward and Parish 1986). Consequently, sterilization of 
male EGS with GonaCon™ may be a potential tool in preventing destructive 
behavior such as gnawing and girdling of trees which causes damage and 
economic losses in urban and suburban areas, like Clemson University’s main 
campus. 
 There were no histological changes in the pituitary glands of EGS that 
received either GonaCon™ or sham control treatments as evidenced from 
necropsy examination of 35 EGS. The pituitary regulates other physiological 
processes in EGS, and it is important that these processes are not disrupted or 
compromised by GonaCon™.  A study of active immunization against GnRH in 
pigs caused damage to cells in the hypothalamus other than those producing 
GnRH (an action called a by-stander effect) (Molenaar et al. 1993).
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CHAPTER 4 
 
 
CONCLUSIONS OF FIELD TRIALS OF GONACONTM IN EASTERN GRAY 
SQUIRRELS AND RECOMMENDATIONS 
 
 
 Results of this study indicate that a single-dose of 400 µg GonaCon™ 
vaccine injected in EGS induced GnRH-titer peaks suggestive of an immunologic  
response that may have inhibited reproduction in treated male and female EGS 
(n = 39:28).   Examination of antibody titers, scrotal size, testicular weights; 
histological assessment of testes, epididymides, and prostates indicates that 
GonaCon™, in all likelihood, was successful in inhibiting breeding in male EGS.  
These results imply that GonaCon™, in this study, caused immunocastration in 
male EGS.  
 It is not clear whether GonaCon™ conferred sterility in female EGS in this 
study.  However, based upon results of antibody titers in female EGS, it is 
evident that GonaCon™ was effective at the immunologic level.  These results, 
however, cannot be extrapolated to imply that breeding was actually inhibited in 
female EGS in this study.  Breeding behavioral observations of GonaCon™ 
treated female EGS were not recorded, and examination of potential parturition in 
GonaCon™ treated female EGS was not an objective of this study.  
 It is also important to examine the potential use of GonaCon™ for EGS in 
context of the 8 criteria developed by Becker and Katz (1997) for what is 
considered an ideal contraceptive agent.  These criteria include reversibility, 
suitability for remote delivery, effectiveness of a single dose, effects on the food 
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chain, harmful side effects, effects on EGS social behavior, costs, and social 
acceptability.    
 Reversibility of immunocontraception restores breeding fitness to the 
target species. For some species, like raccoons and EGS, incriminated as pests 
in urban and suburban areas, the question of reversibility does not arise. 
However immunocastration, due to active immunization against Luteinizing 
Hormone-Releasing Hormone (LHRH) in dogs, was found to be reversible and 
could be dose dependent (Ladd et al. 1994). Further research is required to 
standardize the dosage rate at which GonaCon™ would cause irreversible 
infertility in EGS, if that is an objective of affected stakeholders in urban and 
suburban communities.  
 Suitability for remote delivery is an impediment for GonaCon™ use in 
EGS, as it can only be delivered at the present time by hand injection. 
Consequently, treatment of EGS with GonaCon™ can only be achieved by an 
intensive effort to trap EGS, which can be labor intensive, time-consuming, and 
costly. The potential difficulty of using GonaCon™ to control EGS reproduction 
and populations is compounded in urban and suburban areas, because EGS are 
often viewed with affection by a portion of the public, making control efforts 
problematic and controversial (Moore et al. 1997).  Research at USDA’s National 
Wildlife Research Center is currently underway to develop an oral 
immunocontraceptive which could be delivered without having to trap and handle 
EGS (Miller 1997).  
  
55 
 
 An alternative to GonaCon™ may be a cholesterol analogue called 
DiazaCon™, which inhibits both cholesterol and reproductive hormone 
production.  DiazaCon™ is delivered as bait by over coating a preferred food 
item (e.g. rolled oats for prairie dogs) for a period of 5 to 10 days, and the 
contraceptive effects last up to the length of a targeted species breeding season 
(Yoder et al. 2007).  This product was found to be a potential tool for reducing 
fecundity in black-tailed prairie dogs (Cynomys ludovicionus) (Nash et al. 2007) 
and monk parakeets (Myiopsitta monachus) (Yoder et al. 2007). 
 In a recent (October 2009) and significant development in wildlife 
contraception,  GonaCon™ was licensed by the US Environmental Protection 
Agency (EPA) for use in white-tailed deer at a single dose of 1000 µg (Miller, 
pers. comm.).  It is anticipated that GonaCon™ will also meet the single dose 
administration criteria (Becker and Katz 1997) in EGS.  Its efficacy as a single 
dose administration has proven effective in feral pigs (Massei et al. 2008) and 
feral cats (Levy et al. 2004).  A long-lasting immune response to GonaCon™ 
depends on the retained antigen; therefore, a long-term study is required to 
determine if and when GnRH antibodies decline in EGS. If long-termed efficacy 
is not achieved, then GnRH would not be inhibited resulting in a reversal of 
steriodogenesis, spermatogenesis and oogenesis (Robbins et al. 2004).  
 The manufacturer of GonaCon™, the USDA National Wildlife Research 
Center, has determined that there is no danger associated with humans or 
wildlife consuming animals treated with GonaCon™.  Both GonaCon™, and the 
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antibodies produced by an animal treated with GonaCon™, are proteins that 
once ingested, are broken down by stomach acids and enzymes. The USDA 
Food and Drug Administration (FDA) has also determined that there is little risk 
to humans if meat from deer and pigs treated with GonaCon™ was consumed 
(Fagerstone et al. 2008).   
 There were relatively few harmful side effects observed in EGS treated 
with GonaCon™ in this study. Of the 117 EGS treated in this study, 67 EGS (39 
m, 28f) received GonaCon™ injections and 50 EGS (32m, 18f) the sham control 
injections. Six EGS, 4 treated (2 males, 2 females) and 2 controls (both males), 
developed injection site granulomas with moderate to severe sterile abscess 
formation. Consequently, there was a 7.62% incidence of injection site reactions 
in EGS.  This was likely due to the water-in-oil emulsion present in the 
GonaCon™ formulation (Gupta et al. 1993), or the presence of the bacterium 
Mycobaterium avium in the adjuvant, which is necessary for single shot 
effectiveness (Perry et al. 2008).  Besides the injection site reactions, there were 
no other serious side effects to GonaCon™ observed in EGS in this study.  
 In a separate study, that was conducted in concurrence with this study on 
the same study site, the effects of GonaCon™ on the social behavior of EGS 
was examined.  Eighteen volunteer observers were trained to perform 
instantaneous focal sampling of EGS activity budgets over 10-minute sessions. 
Over 1150 sessions were recorded and analyzed for differences in EGS activity 
budgets between GonaCon™ treated and control EGS. Preliminary results of this 
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study showed that GonaCon™ significantly changed only one behavioral activity 
budget of EGS, that being significantly (p = 0.05) more self-grooming by 
GonaCon™ treated male EGS, as opposed to control male EGS (Etheredge, 
unpublished data).  Additional research is needed to more accurately quantify 
and describe behavioral activity budgets of GonaCon™ treated and control EGS 
over multiple breeding seasons and years. 
 Economics is also an important consideration when evaluating the 
feasibility of wildlife contraception.  Costs of GonaCon™ production and delivery, 
as well as who pays for these expenses, is an issue of debate (Kirkpatrick 2007).  
If GonaCon™ is proven to be effective as a wildlife contraceptive and registered 
for use in EGS, it will in all likelihood remain under the strict control and selective 
use of USDA Wildlife Services.   Although costs of producing GonaCon™ by the 
USDA National Wildlife Research Center are not available, costs of delivery can 
be estimated based upon the effort involved in trapping and treating EGS in this 
study. For example, EGS density on Clemson University’s main campus during 
this study was estimated to be 9 EGS/ha. With 567 ha of EGS habitat on 
Clemson University’s main campus, the EGS population can be estimated to be 
approximately 5,103 squirrels.  A previous study on immunocontraception in 
rodents concluded that over 90% of the population need to be sterilized to 
achieve the desired control (Moore et al. 1997). Based upon this study, 
approximately 4593 EGS would need to be treated with GonaCon™ to have an 
effect on controlling reproduction and consequently overabundance.  Using the 
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best trapping success obtained in this study, the same effort to trap 90% of EGS 
on Clemson’s campus would take 1000 days at a cost of $ 15/EGS.  This 
assumes 2.1 hours/EGS to trap and treat with GonaCon™ at an hourly rate of 
$7.25/hour (2009 minimum wage).  Thus, the labor costs alone for plausible 
success of GonaCon™ in control of EGS would be in the region of $ 70,000.  
 This hypothetical example illustrates the high costs of anti-fertility control 
in EGS, which does not include the costs of the vaccine itself.  Costs may be 
reduced, and effectiveness enhanced, of treating EGS with GonaCon™ if EGS 
populations are reduced before initiating a contraceptive program.  However, this 
integrated approach that includes population reduction, may not be socially 
acceptable within urban and suburban communities having high EGS 
populations. Other studies that have documented expenses associated with 
contraceptive programs concluded it would cost an estimated $25 to $500 to 
treat an individual deer, a wild horse, African elephant or even a captive kudu 
(Rutberg 2005).  Costs of treating EGS with GonaCon™ in urban and suburban 
areas would in all likelihood have to be borne by affected individuals, 
municipalities and other stakeholders that would benefit from EGS population 
control.  
 Social acceptability of using GonaCon™ to control EGS numbers, as well 
as populations of other wildlife species, is another challenge wildlife managers 
face.  A few animal rights groups maintain that wildlife contraception violates the 
reproductive rights of animals (Kirkpatrick 2007). The issue of alteration in 
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population genetics due to wildlife immunocontraception may not arise when 
small, isolated populations of pest species are concerned (Nettles 1997).  
 Longer study duration of up to 5 – 6 years, to coincide with the life span of 
EGS is critical to provide a frame of reference for year-round hormonal profiles in 
both sexes. In addition, a larger sample size of EGS is needed to better 
understand the disparity in GonaCon™ effectiveness observed in male and 
female EGS in this study.  It would take a minimum of one year of continuous 
blood sampling in male and female EGS to establish baseline data for hormonal 
concentrations over a temporal scale of multiple breeding seasons.   
 Wildlife contraception remains a contentious issue and the use of anti-
fertility vaccines for population control and reduction of wildlife damage 
management has both proponents and opponents.  Some proponents are 
researchers and those affected by high EGS populations and subsequent 
damage in urban and suburban communities, as well as activists who seek non-
lethal solutions to human–wildlife conflicts. Some opponents include wildlife 
biologists and managers, recreational hunters, and some animal welfare groups 
who oppose the use of wildlife contraception (Kirpatrick 2007). Despite the 
various perspectives on the use of contraceptives to control growth in wild animal 
populations, continued research is needed. Research to evaluate the use of 
GonaCon™ and other contraceptives can provide answers to questions that 
remain on effectiveness and efficacy, impacts on biology and behavior of target 
and non-target species, costs, and social acceptability.  A key factor in the 
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sustained use of any anti-fertility vaccine is its margin of safety in the target 
species.  It is important that the vaccine formulation used in this study be 
improved to avoid injection site reactions observed in EGS in this study.  
 Continued research should focus on collecting EGS blood samples of 
GonaCon™ treated and control EGS during peak breeding seasons. To 
determine the peak of EGS breeding seasons in local populations, baseline 
hormonal profiles of EGS are needed through at least one year of breeding 
seasons.  This is important for future studies, since this study did not detect any 
significant differences in hormonal concentrations between GonaCon™ treated 
and control EGS.  This was likely a result of peak breeding being missed when 
blood was collected.  Consequently, collection of blood from EGS should 
coincide with peaks in breeding, as collection during post-breeding, to enhance 
the ability to detect differences in GonaCon™ treated and control EGS.  A 
definitive method to determine occurrence of potential breeding, as well as 
potential parturition in GonaCon™ treated EGS, will provide conclusive evidence 
on the efficacy of GonaCon™ as a potential tool for immunocontraception in 
EGS.  
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   Table 1.  EGS trapped as “originals”. 
March- April 
2008 Jul 2008 Nov 2008 
T  C  T  C  T  C  Total  
Male 17 16 14 12 8 4 71 
Female 16 6 9 8 3 4 46 
Total 33 22 23 20 11 8 117 
 
 
 
 
 
 
 
 
   Table 2.  EGS trapped as “recaptures”. 
 
March- April 
2008 Jul 2008 Nov 2008 
May- June 
2009 
T  C  T  C  T  C  T  C  Total  
Male  5    7  17  26  18  17 8  10  108  
Female  3  19  15  13    5  20 8    9    92  
Total  8  26  32  39  23  37 16  19  200  
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Table 3.  EGS capture data sheet. 
 
 
 
 
 
 
 
 
Table 4.  Mean scrotal size (mm) measurements of treated and control EGS 
males. 
 Originals  Recaptures 
 Length (mm) Breadth (mm) Length (mm) Breadth (mm) 
Treated Males 20.41 ± 2.5 13.29 ± 1.89 15.07 ± 1.28 9.11 ± 0.95 
Control Males 7.11 ± 0.26 5.50 ± 0.45 18.04 ± 2.31 11.73 ±1.76 
 
RESEARCH DATA  
SQUIRREL CONTRACEPTION 
RESEARCH PROJECT 
Clemson University 
Department of Forestry and Natural 
Resources 
Principal Investigator: Greg K. Yarrow 
Phone: 864 – 656 – 5334 
Capture, Handling, 
Blood Collection and 
Vaccination Records 
Project ID:  QA-1534 
Site: 
Date: 
Initials: 
Trap# Sex1 Age2 Weight (g) 
Microchip 
Number 
Color 
of Ear 
Tag 
Used3 
Breeding 
Status 
Blood 
Collected 
(ml) 
Vaccine 
ID 
(Batch#) 
Amount 
of 
Vaccine 
given 
(ml) 
Handling Time5 Scrotal 
Size6 
(mm) 
Start End  Mt L B 
                              
               
               
               
1F = female, M = male, U = unknown 
2A = adult, J = juvenile, U = unknown 
3B = Blue, R = Red, G = Green, W = White 
4LT = lactating, NLT = not lactating, P = pigmented scrotum, NP = not pigmented scrotum, T = descended testes, NT = not 
descended testes 
5Time taken in minutes from start of handling to release of animal 
6Scrotal size, length and breadth in mm 
*last revised July 2008 
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Table 5.  Mean testosterone (nmol/1) concentrations of treated and control EGS 
males (B = treated, Y = control). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No Sex 
Color 
of Ear 
Tag 
Microchip 
Number 
Treatment 
Status 
Breeding 
Status 
TESTOSTERONE (ng/ml) 
Season 1 Season 2 Season 3 
1 M B-132 016-069-087 t NPT 0.3 . 0.3 
2 M B-133 016-051-055 t PT 0.2 0.2 0.2 
3 M B-134 016-076-638 t NLT 0.2 0.6 1 
4 M B-135 016-086-001 t NP, NT . 0.5 0.8 
5 M B-137 016-054-004 t NPT 0.4 . 0.3 
6 M B-139 016-039-883 t NP, NT 0.1 . 0.4 
7 M B-191 016-064-337 t PT 0.8 0.1 0.2 
8 M Y-118 016-095-873 c PT 0.3 0.4 0.5 
9 M Y-119 016-064-825 c PT 0.2 0.1 . 
10 M Y-120 016-101-082 c PT 0.5 0.5 . 
11 M Y-125 019-012-327 c PT 0.6 . 0.6 
12 M Y-126 016-099-082 c PT 0.2 . 1.2 
13 M Y-127 019-051-563 c PT 0.3 0.3 . 
14 M Y-128 016-085-082 c PT 0.3 0.1 0.2 
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Table 6.  Mean progesterone concentrations (nmol/1) concentrations of treated 
and control EGS females (W = treated, R = control). 
 
 
No Sex Color of Ear Tag 
Microchip 
Number 
Treatment 
Status 
Breeding 
Status 
PROGESTERONE (ng/ml) 
Season 1 Season 2 Season 3 
1 F W147 016-103-575 t NLT 2.4 . . 
2 F W149 016-044-608 t NLT 1.1 . . 
3 F W150 016-069-045 t NLT . 0.9 . 
4 F W151 016-089-573 t NLT 2.3 . . 
5 F W155 016-083-003 t NLT 1.3 . . 
6 F W157 016-084-556 t NLT 1.2 . . 
7 F W158 015-844-305 t NLT . 0.5 . 
8 F W160 015-792-356 t NLT 1.8 . . 
9 F W171 016-063-543 t NLT 1.6 . . 
10 F W178 019-023-068 t NLT 1.1 1.4 . 
11 F W179 019-034-110 t NLT 1.1 . . 
12 F W180 019-025-256 t NLT 2.8 . . 
13 F R-102 016-076-278 c NLT 1 . 1.6 
14 F R-104 016-088-882 c NLT 0.9 . 2.1 
15 F R-106 016-082-602 c NLT 1.1 1.9 1 
16 F R-107 016-050-802 c NLT 2 0.9 . 
17 F R-111 016-095-798 c NLT 0.9 3 1.1 
18 F R-114 016-083-358 c NLT 0.7 0.6 17.4 
19 F R-168 019-036-348 c NLT 2.2 2.9 . 
  
65 
 
Table 7.  Measured antibody titers of treated and control EGS (R = control 
female, W = treated female, Y = control male, B = treated male). 
MEASURED TITERS 
No Sex 
Color of  
Ear Tag 
Microchip 
Number 
Treatment 
Status 
Breeding 
Status 
Season 
1 
Season 
2 
Season 
3 
1 F R107 016-050-802 c NLT 0 0 . 
2 F R114 016-095-798 c NLT 0 0 0 
3 F R112 019-045-014 c NLT . 0 0 
4 F R49 019-046-542 c NLT 0 0 0 
5 F W150 016-069-045 t NLT 0 128000 . 
6 F W160 015-792-356 t NLT 0 128000 . 
7 F W174 019-010-829 t NLT 0 128000 . 
8 F W178 019-023-068 t NLT . 128000 . 
9 F W82 024-124-828 t NLT 0 128000 
10 M Y127 016-085-082 c NT 0 0 . 
11 M Y128 016-099-082 c NT . 0 0 
12 M Y64 019-032-012 c NT . 0 0 
13 M Y66 016-099-082 c PT . 2000 8000 
14 M B132 016-069-087 t NT 0 128000 . 
15 M B133 016-051-055 t PT 0 128000 . 
16 M B134 016-076-638 t NT 0 128000 128000 
17 M B137 016-054-004 t NT 0 . 128000 
18 M B139 016-039-883 t NT 0 0 64000 
19 M B145 016-051-776 t NPT 0 . 128000 
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Table 8.  EGS males examined on necropsy (Y = control, B = treated). 
Sex 
Color of 
Ear Tag Age 
Weight 
(grams) 
Treatment 
Status 
Microchip 
Number Status 
Scrotal Size 
(mm) Testes 
Weight 
(mg) 
L B 
 
M Y123 A 450 c . 20 784.8 
M B135 A 610 t 016-086-001 PT 18.69 12.4 402.8 
 
M Y119 A 550 c . PT 30.43 20.61 788.63 
M . A 550 t 016.041-341 NPNT . . 238 
M Y69 A 480 c 019-045-855 NPNT . . 147 
M B191 A 490 t 019-064-337 PT 14.84 8.88 512 
M Y129 A 620 c 016-050-529 PT 24.57 14.83 5767 
 
M Y125 A 520 c . PT 36.54 25 5713 
M Y124 A 470 c 016-097-558 PT 31.55 24.69 4641 
M B139 A 470 t 016-039-883 PT 18.81 11.36 401 
M Y64 A 510 c 019-032-012 PT 35.4 22.48 4134 
M B189 A 430 t 019-068-841 NPNT . . 178 
M Y127 A 450 c 019-051-563 PT 34.52 20.45 4130 
M Y117 A 470 c 016-077-309 PT 51.19 29.39 5027 
M B138 A 500 t 015-865-824 PT 10.05 3.18 579 
M B199 A 500 t 019-010-846 NPNT . . 266 
M B97 A 430 t 019-035-635 NPNT . . 182 
 
M Y121 A 540 c . PT 40.11 28.66 5742 
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Table 9.  EGS females examined on necropsy. 
Sex Age 
Weight 
(grams) 
Treatment 
Status 
Microchip 
Number 
Breeding 
Status 
Ovaries 
weight 
(mg) 
Diameter 
of horn 
(mm) 
Length 
of Tract 
(mm) 
F A 470 t 024-298-825 NLT 97 2 70 
F A 520 c 016-082-602 NLT 110 1.91 90 
F A 590 c 019-036-348 NLT 102 1.51 80 
F A 610 c 019-045-014 NLT 109 1.89 90 
F A 490 c 024-278-118 NLT 19 1.61 50 
F A 430 c 019-062-086 NLT 38 1.44 60 
F A 550 t 016-076-558 NLT 52 1.8 55 
F A 410 c . NLT 50 1.71 50 
F A 540 t 024-127-607 NLT 116 2.01 80 
F A 600 c 024-329-607 NLT 112 1.41 90 
F A 480 c 019-042-309 NLT 95 1.1 65 
F A 480 t 019-010-829 NLT 126 2.21 85 
F A 480 t 019-060-865 NLT 102 1.91 65 
F A 430 t 024-124-828 NLT 72 1.14 60 
F A 470 t 016-084-556 NLT 110 2.02 90 
F A 420 t 016-067-085 NLT 108 2 78 
F A 550 c . NLT 288 4 85 
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        Figure 7.  Map of EGS study area. 
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Figure 8.  Modified trap design with capture cone 
 
  
70 
 
 
Figure 9. No significant differences in body weights of control and treated EGS in 
each trapping session TS1 (p = 0.63), TS2 (p = 0.80), TS3 (p = 0.40).
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Figure 10. Significant differences in scrotal size of control and treated EGS males 
by the fourth trapping session TS4 (p = 0.001).  
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Figure 11. No significant differences in testosterone concentrations of control and 
treated EGS males by the third trapping session TS3 (p = 0.32).  
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Figure 12. No significant differences in progesterone concentrations of control 
and treated EGS females by the second trapping session TS2 (p = 0.68).  
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Figure 13. Significant differences in antibody titer activity of control EGS (red) 
and treated EGS (blue) by second trapping and third session, TS2 (p = 0.029) 
and TS3 (p = 0.017).  
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